Document is current
Any future updates will be listed below
-
Authors
Can Karanlık, Ceren
Türkkol, Ayşegül
Karanlık, Gürkan
Kolaç, Umut Kerem
Çalışkan, Şerife Gökçe
Bilgin, Mehmet Dinçer
Erdoğmuş, Ali
-
Funding
Funding for this research was provided by:
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (221Z066)
- License Information
-
More Information
Article History
Received: 22 December 2025
Accepted: 9 April 2026
First Online: 16 April 2026
Declarations
:
: The authors declare no competing interests.
: The human breast cancer cell line MDA-MB-231 was purchased from the ATCC. As this study was conducted exclusively using commercially available established cell lines, no additional ethical approval was required.
